BECN1 and ductal breast carcinoma in situ: Using immunohistochemistry, Espina et al. examined breast comedo-ductal carcinoma in situ and found that BECN1 (Beclin-1) to be upregulated at the viable rim of intraductal cells within the hypoxic ductal niche [57].